US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Axsome Therapeutics

112.21

-0.0800-0.07%

Volume:229.76K

Turnover:25.69M

Market Cap:5.47B

PE:-18.72

High:113.30

Open:111.21

Low:109.88

Close:112.29

Loading ...

Overview Company News Filings

Axsome Therapeutics Shares Down 4.5% After Co's Depression Treatment Fails to Meet Main Goal of Late-Stage Study

THOMSON REUTERS

Axsome Therapeutics Price Target Maintained With a $153.00/Share by Needham

BUZZ-Axsome falls on depression drug's trial setback

Axsome Therapeutics Shares Down 2.5% Premarket After Co's Depression Treatment Fails to Meet Main Goal of Late-Stage Study

THOMSON REUTERS

Axsome's depression treatment fails to meet main goal of late-stage study

Axsome Therapeutics: in Overall Patient Population, Study Did Not Show Statistically Significant Change on Madrs Total Score VS Placebo

THOMSON REUTERS

Axsome Therapeutics Announces Topline Results of Paradigm Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (Mdd) With and Without Excessive Daytime Sleepiness (Eds)

THOMSON REUTERS

Axsome Therapeutics: Results Support Continued Development in Mdd With Concomitant Eds; Phase 3 Trial Planned in 2025

THOMSON REUTERS

Axsome Therapeutics Announces Topline Results of PARADIGM Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (MDD) with and without Excessive Daytime Sleepiness (EDS)

Axsome Therapeutics Is Maintained at Outperform by Mizuho

Axsome Therapeutics Inc : Mizuho Raises Target Price to $216 From $212

THOMSON REUTERS

Mizuho Securities Adjusts Axsome Therapeutics Price Target to $216 From $212, Maintains Outperform Rating

MT Newswires Live

Buy Rating Affirmed for Axsome Therapeutics Amid Promising ADHD Treatment Results and Strategic Market Positioning

Axsome Therapeutics announces FOCUS Phase 3 trial achieved primary endpoint

Axsome Therapeutics’ Promising Phase III FOCUS Trial Results Boost Buy Rating

Axsome Therapeutics' Phase 3 Trial of Solriamfetol to Treat ADHD Meets Primary Endpoint

MT Newswires Live

BRIEF-Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary Endpoint

Axsome Therapeutics' ADHD drug meets main goal in late-stage study

Axsome Therapeutics Inc: Well Tolerated With Safety Profile Generally Consistent With Prior Solriamfetol Trials

THOMSON REUTERS

Axsome Therapeutics Announces Focus Phase 3 Trial of Solriamfetol in Adults With Attention Deficit Hyperactivity Disorder (Adhd) Achieves Primary Endpoint

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AXSM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AXSM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXSM\",,,,,undefined,":{"symbol":"AXSM","market":"US","secType":"STK","nameCN":"Axsome Therapeutics","latestPrice":112.21,"timestamp":1746126229283,"preClose":112.29,"halted":0,"volume":229761,"delay":0,"floatShares":36674187,"shares":48765403,"eps":-5.994374,"marketStatus":"Trading","change":-0.08,"latestTime":"05-01 15:03:49 EDT","open":111.21,"high":113.3,"low":109.875,"amount":25687885.220234998,"amplitude":0.030501,"askPrice":112.27,"askSize":6,"bidPrice":112.11,"bidSize":40,"shortable":3,"etf":0,"ttmEps":-5.994374,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1447909200000,"exchange":"NASDAQ","adjPreClose":112.29,"preHourTrading":{"tag":"盘前","latestPrice":111.82,"preClose":112.29,"latestTime":"09:28 EDT","volume":332,"amount":37516.9794,"timestamp":1746106080006},"postHourTrading":{"tag":"盘后","latestPrice":112.6,"preClose":112.29,"latestTime":"18:18 EDT","volume":84119,"amount":9445816.19,"timestamp":1746051527411},"volumeRatio":0.436995,"impliedVol":0.445,"impliedVolPercentile":0.32},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXSM\",,,,,undefined,":{"symbol":"AXSM","floatShares":36674187,"roa":"-27.28%","roe":"-231.63%","lyrEps":-5.994374,"volumeRatio":0.436995,"shares":48765403,"dividePrice":0,"high":113.3,"amplitude":0.030501,"preClose":112.29,"low":109.875,"week52Low":64.11,"pbRate":"95.97","psRate":"14.19","week52High":139.1299,"institutionHeld":0,"latestPrice":112.21,"committee":0.73913,"eps":-5.994374,"divideRate":0,"volume":229761,"delay":0,"ttmEps":-5.994374,"open":111.21,"prevYearClose":84.61,"prevWeekClose":106.27,"prevMonthClose":112.29,"prevQuarterClose":116.63,"fiveDayClose":105.41,"twentyDayClose":109.75,"sixtyDayClose":112.92,"earningDate":1746374400000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AXSM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524114916","title":"Axsome Therapeutics Shares Down 4.5% After Co's Depression Treatment Fails to Meet Main Goal of Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2524114916","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524114916?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:34","pubTimestamp":1743514496,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF10E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4585","BK4505","AXSM"],"gpt_icon":0},{"id":"2524111969","title":"Axsome Therapeutics Price Target Maintained With a $153.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2524111969","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524111969?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:05","pubTimestamp":1743512700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AXSM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 09:05 ET (13:05 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM"],"gpt_icon":0},{"id":"2524119964","title":"BUZZ-Axsome falls on depression drug's trial setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2524119964","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524119964?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:04","pubTimestamp":1743512648,"startTime":"0","endTime":"0","summary":"BUZZ-Axsome falls on depression drug's trial setback** Drugmaker Axsome Therapeutics' AXSM.O shares fall 3.1% to $113 premarket** AXSM says it will narrow the focus of a late-stage study of its depression drug after it did not show statistically significant improvement in the overall group of patients** However, it helped reduce symptoms in some patients with major depressive disorder who also suffered from excessive daytime sleepiness , a common symptom of MDD** AXSM plans to start a larger late-stage study of the drug in MDD patients with EDS this year ** Solriamfetol is already approved in the U.S. to improve wakefulness in adults with excessive sleepiness from sleep disorders, narcolepsy and sleep apnea** Brokerage Truist Securities says solriamfetol could potentially address the MDD demographic who may be complementary to those addressed by Auvelity, AXSM's FDA-approved treatment for MDD** As of last close, AXSM has risen 46% in the past 12 months ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL3N3QF104:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM","BK4505","BK4585","BK4007"],"gpt_icon":0},{"id":"2524131421","title":"Axsome Therapeutics Shares Down 2.5% Premarket After Co's Depression Treatment Fails to Meet Main Goal of Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2524131421","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524131421?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:26","pubTimestamp":1743510392,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL3N3QF105:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AXSM","BK4007","BK4585","BK4505"],"gpt_icon":0},{"id":"2524268194","title":"Axsome's depression treatment fails to meet main goal of late-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2524268194","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524268194?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:10","pubTimestamp":1743505809,"startTime":"0","endTime":"0","summary":"Axsome's depression treatment fails to meet main goal of late-stage studyApril 1  - Axsome Therapeutics AXSM.O said on Tuesday its experimental drug to treat major depressive disorder failed to meet the main goal of a late-stage study.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL3N3QF0WN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","AXSM","BK4007","BK4505"],"gpt_icon":0},{"id":"2524948451","title":"Axsome Therapeutics: in Overall Patient Population, Study Did Not Show Statistically Significant Change on Madrs Total Score VS Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2524948451","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524948451?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:01","pubTimestamp":1743505309,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF0MU:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4505","BK4585","AXSM"],"gpt_icon":0},{"id":"2524889194","title":"Axsome Therapeutics Announces Topline Results of Paradigm Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (Mdd) With and Without Excessive Daytime Sleepiness (Eds)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524889194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524889194?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:01","pubTimestamp":1743505309,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF0MU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4505","BK4585","AXSM"],"gpt_icon":0},{"id":"2524119488","title":"Axsome Therapeutics: Results Support Continued Development in Mdd With Concomitant Eds; Phase 3 Trial Planned in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524119488","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524119488?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:01","pubTimestamp":1743505309,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF0MU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AXSM","BK4585","BK4505","BK4007"],"gpt_icon":0},{"id":"2524619454","title":"Axsome Therapeutics Announces Topline Results of PARADIGM Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (MDD) with and without Excessive Daytime Sleepiness (EDS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524619454","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524619454?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505200,"startTime":"0","endTime":"0","summary":"Results support continued development in MDD with concomitant EDS; Phase 3 trial planned in 2025 Approximately 50 percent of MDD patients experience EDS1, highlighting high unmet need NEW YORK, April ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/01/3053170/33090/en/Axsome-Therapeutics-Announces-Topline-Results-of-PARADIGM-Phase-3-Proof-of-Concept-Trial-of-Solriamfetol-in-Major-Depressive-Disorder-MDD-with-and-without-Excessive-Daytime-Sleepin.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","ESS","BK4007","AXSM","CNS","BK4597","BK4585","BK4588","PACI.U","BK4215","BK4135","ADHD","ABVC","BK4139"],"gpt_icon":0},{"id":"2522308125","title":"Axsome Therapeutics Is Maintained at Outperform by Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2522308125","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522308125?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:48","pubTimestamp":1743079680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AXSM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2025 08:48 ET (12:48 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MFG","AXSM"],"gpt_icon":0},{"id":"2522932721","title":"Axsome Therapeutics Inc : Mizuho Raises Target Price to $216 From $212","url":"https://stock-news.laohu8.com/highlight/detail?id=2522932721","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522932721?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:34","pubTimestamp":1743071690,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA0GD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4585","AXSM","BK4007"],"gpt_icon":0},{"id":"2522872000","title":"Mizuho Securities Adjusts Axsome Therapeutics Price Target to $216 From $212, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2522872000","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522872000?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:17","pubTimestamp":1742991442,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (AXSM) has an average rating of Buy and mean price target of $176.63, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AXSM","MFG"],"gpt_icon":0},{"id":"2522845871","title":"Buy Rating Affirmed for Axsome Therapeutics Amid Promising ADHD Treatment Results and Strategic Market Positioning","url":"https://stock-news.laohu8.com/highlight/detail?id=2522845871","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522845871?lang=en_us&edition=fundamental","pubTime":"2025-03-26 16:35","pubTimestamp":1742978128,"startTime":"0","endTime":"0","summary":"Analyst Jason Gerberry from Bank of America Securities maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) and increased the pr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-affirmed-for-axsome-therapeutics-amid-promising-adhd-treatment-results-and-strategic-market-positioning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-affirmed-for-axsome-therapeutics-amid-promising-adhd-treatment-results-and-strategic-market-positioning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM","ABVC","ADHD"],"gpt_icon":0},{"id":"2522039881","title":"Axsome Therapeutics announces FOCUS Phase 3 trial achieved primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522039881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522039881?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:57","pubTimestamp":1742929045,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (AXSM) announced that the FOCUS Phase 3 trial of solriamfetol in the treatment of attention deficit hyperactivity disorder achi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-announces-focus-phase-3-trial-achieved-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-announces-focus-phase-3-trial-achieved-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4585","AXSM","BK4007"],"gpt_icon":0},{"id":"2522885337","title":"Axsome Therapeutics’ Promising Phase III FOCUS Trial Results Boost Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2522885337","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522885337?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:35","pubTimestamp":1742916935,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their bullish stance on AXSM stock, giving a Buy rating today. Myles Minter’s rating is based on ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/axsome-therapeutics-promising-phase-iii-focus-trial-results-boost-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/axsome-therapeutics-promising-phase-iii-focus-trial-results-boost-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["III","AXSM"],"gpt_icon":0},{"id":"2522021437","title":"Axsome Therapeutics' Phase 3 Trial of Solriamfetol to Treat ADHD Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522021437","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522021437?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:45","pubTimestamp":1742903124,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics  said Tuesday that the phase 3 trial of solriamfetol as a potential treatment for attention deficit hyperactivity disorder achieved its primary and key secondary endpoints, demonstrating \"statistically significant\" improvement in symptoms and disease severity.The study met its primary endpoint of a statistically significant reduction in the Adult ADHD Investigator Symptom Rating Scale compared with placebo at week six. The study also achieved the key secondary endpoint of a significant reduction in overall ADHD disease severity, Axsome added.Solriamfetol was also well-tolerated in the study, with no serious adverse events reported, according to Axsome.Axsome Chief Executive Officer Herriot Tabuteau said the company plans to start a solriamfetol trial in pediatric patients this year.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","BK4585","BK4007","ABVC","ADHD","BK4139","AXSM"],"gpt_icon":0},{"id":"2522021451","title":"BRIEF-Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522021451","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522021451?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:45","pubTimestamp":1742903113,"startTime":"0","endTime":"0","summary":"BRIEF-Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary EndpointMarch 25 (Reuters) - Axsome Therapeutics","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q804P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4585","BK4007","AXSM"],"gpt_icon":0},{"id":"2522023160","title":"Axsome Therapeutics' ADHD drug meets main goal in late-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2522023160","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522023160?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:09","pubTimestamp":1742900972,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics' ADHD drug meets main goal in late-stage studyMarch 25  - Axsome Therapeutics AXSM.O said on Tuesday its experimental drug to treat attention deficit hyperactivity disorder  met the main goal in a late-stage study.    ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL3N3Q80OP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4007","BK4585","AXSM"],"gpt_icon":0},{"id":"2522702382","title":"Axsome Therapeutics Inc: Well Tolerated With Safety Profile Generally Consistent With Prior Solriamfetol Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2522702382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522702382?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:03","pubTimestamp":1742900595,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q804P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AXSM","BK4007","BK4585","BK4505"],"gpt_icon":0},{"id":"2522028022","title":"Axsome Therapeutics Announces Focus Phase 3 Trial of Solriamfetol in Adults With Attention Deficit Hyperactivity Disorder (Adhd) Achieves Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522028022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522028022?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:03","pubTimestamp":1742900595,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q804P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","AXSM","BK4007","BK4585"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AXSM\",params:#limit:5,,,undefined,":[{"date":"2025-05-05","symbol":"AXSM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-1.26,"defaultRemindTime":1746432000000,"name":null,"time":"Pre-Market","dateTimestamp":1746417600000,"actualEps":null},{"market":"US","date":"2025-02-18","symbol":"AXSM","fiscalQuarterEnding":"2024/12","expectedEps":-0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739854800000,"reportTimeType":"pre","actualEps":-0.96},{"market":"US","date":"2025-01-13","symbol":"AXSM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-12","symbol":"AXSM","fiscalQuarterEnding":"2024/09","expectedEps":-1.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.34},{"market":"US","date":"2024-08-05","symbol":"AXSM","fiscalQuarterEnding":"2024/06","expectedEps":-1.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"pre","actualEps":-1.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AXSM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AXSM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":18,"updateTime":1743998400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AXSM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AXSM","date":"2025-04-30","current":-18.662085,"percent":0.413961,"low":-51.551215,"twenty":-23.679617,"median":-16.742979,"eighty":-12.087351,"high":-6.009438,"avg":-18.713198,"sd":8.583962,"marketCap":5360049270},"quantilePoints":[{"date":"2020-05-01","current":-48.893097,"twenty":-22.842924,"median":-8.988352,"eighty":-3.33802,"marketCap":3341607784},{"date":"2020-05-08","current":-47.721355,"twenty":-22.969775,"median":-9.013947,"eighty":-3.3411,"marketCap":3261524873},{"date":"2020-05-15","current":-47.130723,"twenty":-23.061156,"median":-9.035407,"eighty":-3.3411,"marketCap":3221158014},{"date":"2020-05-22","current":-43.886688,"twenty":-23.112438,"median":-9.081016,"eighty":-3.3411,"marketCap":2999443869},{"date":"2020-05-29","current":-41.760164,"twenty":-23.194936,"median":-9.081073,"eighty":-3.3411,"marketCap":2854106169},{"date":"2020-06-05","current":-41.977156,"twenty":-23.271382,"median":-9.08113,"eighty":-3.3411,"marketCap":2868936546},{"date":"2020-06-12","current":-39.20508,"twenty":-23.309919,"median":-9.109467,"eighty":-3.3411,"marketCap":2679478472},{"date":"2020-06-19","current":-43.159764,"twenty":-23.388867,"median":-9.173679,"eighty":-3.34216,"marketCap":2949762104},{"date":"2020-06-26","current":-46.539419,"twenty":-23.453022,"median":-9.194644,"eighty":-3.347892,"marketCap":3180745235},{"date":"2020-07-02","current":-43.924662,"twenty":-23.537303,"median":-9.195895,"eighty":-3.355422,"marketCap":3002039185},{"date":"2020-07-10","current":-45.047597,"twenty":-23.575997,"median":-9.252351,"eighty":-3.360692,"marketCap":3078786389},{"date":"2020-07-17","current":-44.293549,"twenty":-23.688243,"median":-9.27672,"eighty":-3.360692,"marketCap":3027250827},{"date":"2020-07-24","current":-41.960882,"twenty":-23.79365,"median":-9.359006,"eighty":-3.361445,"marketCap":2867824268},{"date":"2020-07-31","current":-38.695148,"twenty":-23.90843,"median":-9.369936,"eighty":-3.364772,"marketCap":2644627085},{"date":"2020-08-07","current":-42.351468,"twenty":-24.001264,"median":-9.445345,"eighty":-3.367789,"marketCap":2894518948},{"date":"2020-08-14","current":-31.085393,"twenty":-24.144138,"median":-9.496431,"eighty":-3.374808,"marketCap":2945457014},{"date":"2020-08-21","current":-30.522708,"twenty":-24.239696,"median":-9.535186,"eighty":-3.37804,"marketCap":2892140513},{"date":"2020-08-28","current":-29.987567,"twenty":-24.493059,"median":-9.615634,"eighty":-3.390967,"marketCap":2841433911},{"date":"2020-09-04","current":-26.890832,"twenty":-24.785116,"median":-9.672397,"eighty":-3.390967,"marketCap":2548006738},{"date":"2020-09-11","current":-28.736281,"twenty":-25.060244,"median":-9.751865,"eighty":-3.390967,"marketCap":2722869945},{"date":"2020-09-18","current":-32.12813,"twenty":-25.208723,"median":-9.865391,"eighty":-3.390967,"marketCap":3044260318},{"date":"2020-09-25","current":-30.30629,"twenty":-26.023431,"median":-10.00765,"eighty":-3.390967,"marketCap":2871634167},{"date":"2020-10-02","current":-27.740762,"twenty":-26.53307,"median":-10.090701,"eighty":-3.390967,"marketCap":2628540753},{"date":"2020-10-09","current":-29.354054,"twenty":-27.382689,"median":-10.228673,"eighty":-3.416217,"marketCap":2781406243},{"date":"2020-10-16","current":-29.015656,"twenty":-28.035876,"median":-10.330949,"eighty":-3.42888,"marketCap":2749341774},{"date":"2020-10-23","current":-28.087029,"twenty":-28.082185,"median":-10.398962,"eighty":-3.42888,"marketCap":2661350907},{"date":"2020-10-30","current":-26.092055,"twenty":-28.035876,"median":-10.444372,"eighty":-3.440834,"marketCap":2472319678},{"date":"2020-11-06","current":-25.564895,"twenty":-28.035876,"median":-10.489783,"eighty":-3.440834,"marketCap":2519239799},{"date":"2020-11-13","current":-28.111531,"twenty":-28.035876,"median":-10.687485,"eighty":-3.440834,"marketCap":2770192830},{"date":"2020-11-20","current":-27.452134,"twenty":-28.082185,"median":-10.932533,"eighty":-3.440834,"marketCap":2705213920},{"date":"2020-11-27","current":-28.490495,"twenty":-28.083154,"median":-11.119611,"eighty":-3.45465,"marketCap":2807537031},{"date":"2020-12-04","current":-30.339838,"twenty":-28.091929,"median":-11.258606,"eighty":-3.484182,"marketCap":2989776732},{"date":"2020-12-11","current":-30.059405,"twenty":-28.419132,"median":-11.329873,"eighty":-3.490702,"marketCap":2962142023},{"date":"2020-12-18","current":-29.661493,"twenty":-28.560787,"median":-11.457113,"eighty":-3.490702,"marketCap":2922930612},{"date":"2020-12-24","current":-32.177812,"twenty":-28.75014,"median":-11.558574,"eighty":-3.490702,"marketCap":3170896106},{"date":"2020-12-31","current":-30.874177,"twenty":-28.947976,"median":-11.582928,"eighty":-3.498176,"marketCap":3042432055},{"date":"2021-01-08","current":-29.449273,"twenty":-29.095272,"median":-11.714853,"eighty":-3.516148,"marketCap":2902017859},{"date":"2021-01-15","current":-29.085468,"twenty":-29.198234,"median":-11.798821,"eighty":-3.532002,"marketCap":2866167426},{"date":"2021-01-22","current":-28.289644,"twenty":-29.165155,"median":-11.860918,"eighty":-3.540569,"marketCap":2787744604},{"date":"2021-01-29","current":-25.803642,"twenty":-29.16126,"median":-11.953582,"eighty":-3.54161,"marketCap":2542766646},{"date":"2021-02-05","current":-28.517022,"twenty":-29.142048,"median":-12.324236,"eighty":-3.552989,"marketCap":2810151125},{"date":"2021-02-12","current":-28.282065,"twenty":-29.117759,"median":-12.416899,"eighty":-3.583568,"marketCap":2786997720},{"date":"2021-02-19","current":-27.38771,"twenty":-29.085468,"median":-12.602226,"eighty":-3.590436,"marketCap":2698865406},{"date":"2021-02-26","current":-25.526998,"twenty":-29.049432,"median":-12.694889,"eighty":-3.590436,"marketCap":2515505379},{"date":"2021-03-05","current":-23.635339,"twenty":-29.023526,"median":-12.694889,"eighty":-3.613962,"marketCap":2432090525},{"date":"2021-03-12","current":-24.169696,"twenty":-29.015656,"median":-12.940357,"eighty":-3.730855,"marketCap":2487076269},{"date":"2021-03-19","current":-23.482665,"twenty":-28.846457,"median":-13.52886,"eighty":-3.760079,"marketCap":2416380312},{"date":"2021-03-26","current":-21.534258,"twenty":-28.838588,"median":-13.621523,"eighty":-3.76982,"marketCap":2215888076},{"date":"2021-04-01","current":-20.901753,"twenty":-28.78446,"median":-13.760518,"eighty":-3.76982,"marketCap":2150802910},{"date":"2021-04-09","current":-19.262328,"twenty":-28.770928,"median":-13.971843,"eighty":-3.76982,"marketCap":1982105151},{"date":"2021-04-16","current":-19.425907,"twenty":-28.764865,"median":-14.131173,"eighty":-3.800991,"marketCap":1998937521},{"date":"2021-04-23","current":-19.307504,"twenty":-28.757285,"median":-14.335102,"eighty":-3.816578,"marketCap":1986753718},{"date":"2021-04-30","current":-22.070934,"twenty":-28.740179,"median":-14.508939,"eighty":-3.818526,"marketCap":2271112305},{"date":"2021-05-07","current":-20.793258,"twenty":-28.736281,"median":-14.681183,"eighty":-3.818526,"marketCap":2139638718},{"date":"2021-05-14","current":-22.019873,"twenty":-28.701655,"median":-14.801134,"eighty":-3.818526,"marketCap":2194862183},{"date":"2021-05-21","current":-20.870256,"twenty":-28.655296,"median":-14.864222,"eighty":-3.826319,"marketCap":2080272494},{"date":"2021-05-28","current":-22.883028,"twenty":-28.636775,"median":-14.92072,"eighty":-3.83606,"marketCap":2280898376},{"date":"2021-06-04","current":-23.112951,"twenty":-28.62768,"median":-15.069857,"eighty":-3.849697,"marketCap":2303816314},{"date":"2021-06-11","current":-25.023953,"twenty":-28.565893,"median":-15.2723,"eighty":-3.85749,"marketCap":2494298192},{"date":"2021-06-18","current":-25.3858,"twenty":-28.525855,"median":-15.395896,"eighty":-3.892558,"marketCap":2530365766},{"date":"2021-06-25","current":-27.70388,"twenty":-28.520054,"median":-15.583979,"eighty":-3.962694,"marketCap":2761423665},{"date":"2021-07-02","current":-24.89203,"twenty":-28.501106,"median":-15.829585,"eighty":-4.001321,"marketCap":2481148555},{"date":"2021-07-09","current":-24.620645,"twenty":-28.488077,"median":-16.072993,"eighty":-4.020803,"marketCap":2454097874},{"date":"2021-07-16","current":-20.436794,"twenty":-28.467162,"median":-16.281692,"eighty":-4.296588,"marketCap":2037066545},{"date":"2021-07-23","current":-20.233255,"twenty":-28.441204,"median":-16.586109,"eighty":-4.680907,"marketCap":2016778535},{"date":"2021-07-30","current":-18.314715,"twenty":-28.433613,"median":-16.793478,"eighty":-4.685848,"marketCap":1825545250},{"date":"2021-08-06","current":-19.283408,"twenty":-28.418818,"median":-17.12943,"eighty":-4.706221,"marketCap":1922101152},{"date":"2021-08-13","current":-7.580584,"twenty":-28.417086,"median":-16.637241,"eighty":-4.716408,"marketCap":861409331},{"date":"2021-08-20","current":-7.149492,"twenty":-28.417086,"median":-16.132105,"eighty":-4.716408,"marketCap":812422798},{"date":"2021-08-27","current":-7.958618,"twenty":-28.417086,"median":-15.583979,"eighty":-4.716408,"marketCap":904366752},{"date":"2021-09-03","current":-8.850647,"twenty":-28.417086,"median":-15.2723,"eighty":-4.716408,"marketCap":1005731192},{"date":"2021-09-10","current":-9.082773,"twenty":-28.417086,"median":-14.928377,"eighty":-4.716408,"marketCap":1032108555},{"date":"2021-09-17","current":-9.855422,"twenty":-28.417086,"median":-14.839801,"eighty":-4.716408,"marketCap":1119907494},{"date":"2021-09-24","current":-11.075744,"twenty":-28.417086,"median":-14.51997,"eighty":-4.716408,"marketCap":1258577063},{"date":"2021-10-01","current":-11.36756,"twenty":-28.417086,"median":-14.177504,"eighty":-4.716408,"marketCap":1291737177},{"date":"2021-10-08","current":-10.677813,"twenty":-28.417086,"median":-13.899514,"eighty":-4.716408,"marketCap":1213358725},{"date":"2021-10-15","current":-13.297524,"twenty":-28.417086,"median":-13.602473,"eighty":-4.716408,"marketCap":1511046114},{"date":"2021-10-22","current":-13.297524,"twenty":-28.417086,"median":-13.469961,"eighty":-4.716408,"marketCap":1511046114},{"date":"2021-10-29","current":-12.76695,"twenty":-28.417086,"median":-13.144984,"eighty":-4.716408,"marketCap":1450754998},{"date":"2021-11-05","current":-13.330685,"twenty":-28.417086,"median":-13.115139,"eighty":-4.716408,"marketCap":1514814309},{"date":"2021-11-12","current":-11.782465,"twenty":-28.417086,"median":-12.97288,"eighty":-4.716408,"marketCap":1479777437},{"date":"2021-11-19","current":-10.744071,"twenty":-28.417086,"median":-12.694889,"eighty":-4.716408,"marketCap":1349364041},{"date":"2021-11-26","current":-11.080198,"twenty":-28.417086,"median":-12.602226,"eighty":-4.716408,"marketCap":1391578782},{"date":"2021-12-03","current":-9.675666,"twenty":-28.417086,"median":-12.509562,"eighty":-4.716408,"marketCap":1215181471},{"date":"2021-12-10","current":-9.94877,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1249480948},{"date":"2021-12-17","current":-10.594014,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1330518174},{"date":"2021-12-23","current":-11.539372,"twenty":-28.417086,"median":-12.235636,"eighty":-4.716408,"marketCap":1449247133},{"date":"2021-12-31","current":-11.338296,"twenty":-28.417086,"median":-11.768255,"eighty":-4.716408,"marketCap":1423993672},{"date":"2022-01-07","current":-9.876742,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1240434933},{"date":"2022-01-14","current":-8.583252,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1077983563},{"date":"2022-01-21","current":-7.114196,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":893482530},{"date":"2022-01-28","current":-7.898993,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":992046412},{"date":"2022-02-04","current":-8.616265,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1082129654},{"date":"2022-02-11","current":-9.621646,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1208396959},{"date":"2022-02-18","current":-8.874363,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1114544544},{"date":"2022-02-25","current":-8.460206,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1062529953},{"date":"2022-03-04","current":-8.825214,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1150834298},{"date":"2022-03-11","current":-9.674984,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1261646828},{"date":"2022-03-18","current":-9.916932,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1293197618},{"date":"2022-03-25","current":-10.433285,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1360531621},{"date":"2022-04-01","current":-12.95604,"twenty":-28.415355,"median":-11.795362,"eighty":-4.726594,"marketCap":1689506320},{"date":"2022-04-08","current":-12.00595,"twenty":-28.415355,"median":-12.224063,"eighty":-4.726594,"marketCap":1565611755},{"date":"2022-04-14","current":-10.875874,"twenty":-28.415355,"median":-12.224063,"eighty":-4.726594,"marketCap":1418246480},{"date":"2022-04-22","current":-11.667797,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1521515699},{"date":"2022-04-29","current":-9.47449,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1235501878},{"date":"2022-05-06","current":-8.242936,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1160402061},{"date":"2022-05-13","current":-7.712204,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1085688045},{"date":"2022-05-20","current":-8.74879,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1231613857},{"date":"2022-05-27","current":-7.314154,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1029652533},{"date":"2022-06-03","current":-7.057081,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":993462931},{"date":"2022-06-10","current":-6.730902,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":947544942},{"date":"2022-06-17","current":-6.272039,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":882948449},{"date":"2022-06-24","current":-6.761308,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":951825433},{"date":"2022-07-01","current":-11.233834,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1581446672},{"date":"2022-07-08","current":-12.604892,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1774457880},{"date":"2022-07-15","current":-12.076924,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1700132999},{"date":"2022-07-22","current":-11.142614,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1568605200},{"date":"2022-07-29","current":-10.667166,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1501673894},{"date":"2022-08-05","current":-12.007818,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1690404612},{"date":"2022-08-12","current":-12.438313,"twenty":-28.417086,"median":-12.604892,"eighty":-4.716408,"marketCap":1864871817},{"date":"2022-08-19","current":-16.008246,"twenty":-28.417086,"median":-12.734015,"eighty":-4.716408,"marketCap":2400110584},{"date":"2022-08-26","current":-19.19834,"twenty":-28.417086,"median":-13.012341,"eighty":-4.716408,"marketCap":2878400274},{"date":"2022-09-02","current":-18.014352,"twenty":-28.417086,"median":-13.144984,"eighty":-4.716408,"marketCap":2700885345},{"date":"2022-09-09","current":-17.751244,"twenty":-28.417086,"median":-13.297524,"eighty":-4.716408,"marketCap":2661437584},{"date":"2022-09-16","current":-16.93046,"twenty":-28.417086,"median":-13.546231,"eighty":-4.716408,"marketCap":2538377718},{"date":"2022-09-23","current":-14.373731,"twenty":-28.417086,"median":-13.785155,"eighty":-4.716408,"marketCap":2155048380},{"date":"2022-09-30","current":-12.760762,"twenty":-28.417086,"median":-13.785155,"eighty":-4.716408,"marketCap":1913216449},{"date":"2022-10-07","current":-13.103947,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1964670051},{"date":"2022-10-14","current":-13.7274,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":2058144096},{"date":"2022-10-21","current":-11.862761,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1778579522},{"date":"2022-10-28","current":-12.102991,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1814597044},{"date":"2022-11-04","current":-16.327026,"twenty":-28.417086,"median":-13.971843,"eighty":-4.716408,"marketCap":2447905134},{"date":"2022-11-11","current":-16.029117,"twenty":-28.417086,"median":-14.373731,"eighty":-4.767341,"marketCap":2562577819},{"date":"2022-11-18","current":-15.257677,"twenty":-28.417086,"median":-14.497908,"eighty":-4.79395,"marketCap":2439247519},{"date":"2022-11-25","current":-15.434239,"twenty":-28.417086,"median":-14.724173,"eighty":-4.898255,"marketCap":2467474524},{"date":"2022-12-02","current":-20.888648,"twenty":-28.417086,"median":-14.896404,"eighty":-4.898255,"marketCap":3339471857},{"date":"2022-12-09","current":-20.334515,"twenty":-28.417086,"median":-14.934267,"eighty":-4.898255,"marketCap":3250882487},{"date":"2022-12-16","current":-21.296099,"twenty":-28.417086,"median":-15.271259,"eighty":-4.898255,"marketCap":3404611100},{"date":"2022-12-23","current":-20.043867,"twenty":-28.417086,"median":-15.412018,"eighty":-4.898255,"marketCap":3204416493},{"date":"2022-12-30","current":-20.951124,"twenty":-28.417086,"median":-15.545609,"eighty":-4.898255,"marketCap":3349459875},{"date":"2023-01-06","current":-18.46839,"twenty":-28.417086,"median":-15.702202,"eighty":-6.20404,"marketCap":2952544754},{"date":"2023-01-13","current":-18.280963,"twenty":-28.417086,"median":-16.029117,"eighty":-6.567519,"marketCap":2922580702},{"date":"2023-01-20","current":-19.23983,"twenty":-28.417086,"median":-16.281692,"eighty":-6.731359,"marketCap":3075875054},{"date":"2023-01-27","current":-19.087715,"twenty":-28.417086,"median":-16.637241,"eighty":-6.946485,"marketCap":3051556403},{"date":"2023-02-03","current":-18.66125,"twenty":-28.417086,"median":-17.062014,"eighty":-7.089998,"marketCap":2983377329},{"date":"2023-02-10","current":-17.055894,"twenty":-28.417086,"median":-17.13163,"eighty":-7.187,"marketCap":2726728711},{"date":"2023-02-17","current":-18.096252,"twenty":-28.417086,"median":-17.237888,"eighty":-7.373862,"marketCap":2893050912},{"date":"2023-02-24","current":-16.583251,"twenty":-28.417086,"median":-17.237888,"eighty":-7.712635,"marketCap":2651167190},{"date":"2023-03-03","current":-15.180365,"twenty":-28.417086,"median":-17.237888,"eighty":-7.893661,"marketCap":2840757185},{"date":"2023-03-10","current":-13.578148,"twenty":-28.417086,"median":-17.237888,"eighty":-8.043265,"marketCap":2540928493},{"date":"2023-03-17","current":-14.589708,"twenty":-28.417086,"median":-17.237888,"eighty":-8.219199,"marketCap":2730225272},{"date":"2023-03-24","current":-14.408325,"twenty":-28.417086,"median":-17.237888,"eighty":-8.347465,"marketCap":2696282401},{"date":"2023-03-31","current":-14.343213,"twenty":-28.415355,"median":-17.237888,"eighty":-8.438189,"marketCap":2684097781},{"date":"2023-04-06","current":-13.582799,"twenty":-28.415355,"median":-17.237888,"eighty":-8.515067,"marketCap":2541798823},{"date":"2023-04-14","current":-15.126881,"twenty":-28.417086,"median":-17.237888,"eighty":-8.590342,"marketCap":2830748390},{"date":"2023-04-21","current":-16.577945,"twenty":-28.417086,"median":-17.237888,"eighty":-8.633548,"marketCap":3102291356},{"date":"2023-04-28","current":-16.560131,"twenty":-28.417086,"median":-17.237888,"eighty":-8.782049,"marketCap":3098957798},{"date":"2023-05-05","current":-16.557804,"twenty":-28.417086,"median":-17.237888,"eighty":-8.912326,"marketCap":3098522307},{"date":"2023-05-12","current":-21.39324,"twenty":-28.417086,"median":-17.328154,"eighty":-9.013947,"marketCap":3395527537},{"date":"2023-05-19","current":-21.103076,"twenty":-28.417086,"median":-17.513874,"eighty":-9.093997,"marketCap":3349472883},{"date":"2023-05-26","current":-18.692708,"twenty":-28.417086,"median":-17.629041,"eighty":-9.135139,"marketCap":2966900073},{"date":"2023-06-02","current":-19.97476,"twenty":-28.417086,"median":-17.77844,"eighty":-9.187407,"marketCap":3170386977},{"date":"2023-06-09","current":-20.655593,"twenty":-28.417086,"median":-17.924982,"eighty":-9.24781,"marketCap":3278448546},{"date":"2023-06-16","current":-23.233424,"twenty":-28.417086,"median":-18.014352,"eighty":-9.337052,"marketCap":3687601016},{"date":"2023-06-23","current":-24.803733,"twenty":-28.418818,"median":-18.297839,"eighty":-9.445345,"marketCap":3936839794},{"date":"2023-06-30","current":-20.073591,"twenty":-28.420549,"median":-18.46839,"eighty":-9.469338,"marketCap":3186073334},{"date":"2023-07-07","current":-20.290469,"twenty":-28.420549,"median":-18.576208,"eighty":-9.560131,"marketCap":3220496172},{"date":"2023-07-14","current":-20.040647,"twenty":-28.420549,"median":-18.698313,"eighty":-9.653222,"marketCap":3180844549},{"date":"2023-07-21","current":-20.433224,"twenty":-28.420549,"median":-18.862469,"eighty":-9.751865,"marketCap":3243154243},{"date":"2023-07-28","current":-21.245831,"twenty":-28.420549,"median":-18.946466,"eighty":-9.838866,"marketCap":3372130954},{"date":"2023-08-04","current":-20.666574,"twenty":-28.420549,"median":-19.022523,"eighty":-9.919098,"marketCap":3280191474},{"date":"2023-08-11","current":-18.037146,"twenty":-28.420549,"median":-19.022523,"eighty":-9.959731,"marketCap":3326963385},{"date":"2023-08-18","current":-17.717339,"twenty":-28.420549,"median":-19.022523,"eighty":-10.057126,"marketCap":3267974672},{"date":"2023-08-25","current":-19.290792,"twenty":-28.420549,"median":-19.061023,"eighty":-10.126968,"marketCap":3558199138},{"date":"2023-09-01","current":-20.672361,"twenty":-28.420549,"median":-19.094946,"eighty":-10.228966,"marketCap":3813030376},{"date":"2023-09-08","current":-20.830985,"twenty":-28.420549,"median":-19.19834,"eighty":-10.246301,"marketCap":3842288777},{"date":"2023-09-15","current":-19.495469,"twenty":-28.420549,"median":-19.262328,"eighty":-10.349328,"marketCap":3595951914},{"date":"2023-09-22","current":-19.119375,"twenty":-28.420549,"median":-19.262328,"eighty":-10.378868,"marketCap":3526581188},{"date":"2023-09-29","current":-18.692112,"twenty":-28.420549,"median":-19.262328,"eighty":-10.440043,"marketCap":3447772268},{"date":"2023-10-06","current":-17.23379,"twenty":-28.420549,"median":-19.262328,"eighty":-10.525456,"marketCap":3178783739},{"date":"2023-10-13","current":-17.016321,"twenty":-28.420549,"median":-19.262328,"eighty":-10.598456,"marketCap":3138671414},{"date":"2023-10-20","current":-16.438109,"twenty":-28.420549,"median":-19.262328,"eighty":-10.646711,"marketCap":3032019822},{"date":"2023-10-27","current":-16.386939,"twenty":-28.429835,"median":-19.282946,"eighty":-10.674305,"marketCap":3022581628},{"date":"2023-11-03","current":-16.476485,"twenty":-28.429835,"median":-19.282946,"eighty":-10.808289,"marketCap":3039098468},{"date":"2023-11-10","current":-14.081381,"twenty":-28.429835,"median":-19.282946,"eighty":-10.929836,"marketCap":2842011992},{"date":"2023-11-17","current":-13.999321,"twenty":-28.429835,"median":-19.282946,"eighty":-11.058288,"marketCap":2825450151},{"date":"2023-11-24","current":-14.665174,"twenty":-28.429835,"median":-19.282946,"eighty":-11.129652,"marketCap":2959837664},{"date":"2023-12-01","current":-15.814005,"twenty":-28.429835,"median":-19.282946,"eighty":-11.282106,"marketCap":3191703445},{"date":"2023-12-08","current":-16.46579,"twenty":-28.426058,"median":-19.282946,"eighty":-11.336853,"marketCap":3323251785},{"date":"2023-12-15","current":-17.178534,"twenty":-28.426058,"median":-19.282946,"eighty":-11.380162,"marketCap":3467103208},{"date":"2023-12-22","current":-16.993315,"twenty":-28.426058,"median":-19.282946,"eighty":-11.419937,"marketCap":3429720766},{"date":"2023-12-29","current":-18.667325,"twenty":-28.429835,"median":-19.282946,"eighty":-11.503011,"marketCap":3767582332},{"date":"2024-01-05","current":-19.222984,"twenty":-28.433613,"median":-19.282946,"eighty":-11.566713,"marketCap":3879729658},{"date":"2024-01-12","current":-20.245209,"twenty":-28.433613,"median":-19.306357,"eighty":-11.683287,"marketCap":4086042883},{"date":"2024-01-19","current":-19.811466,"twenty":-28.43739,"median":-19.389342,"eighty":-11.809472,"marketCap":3998501721},{"date":"2024-01-26","current":-21.239299,"twenty":-28.433613,"median":-19.465893,"eighty":-11.861401,"marketCap":4286677762},{"date":"2024-02-02","current":-21.909841,"twenty":-28.433613,"median":-19.601888,"eighty":-11.983144,"marketCap":4422011667},{"date":"2024-02-09","current":-22.432676,"twenty":-28.433613,"median":-19.675324,"eighty":-12.075057,"marketCap":4527534256},{"date":"2024-02-16","current":-21.912185,"twenty":-28.433613,"median":-19.76274,"eighty":-12.186969,"marketCap":4422484862},{"date":"2024-02-23","current":-15.927086,"twenty":-28.433613,"median":-19.76274,"eighty":-12.293238,"marketCap":3810364180},{"date":"2024-03-01","current":-16.115026,"twenty":-28.429835,"median":-19.739727,"eighty":-12.506682,"marketCap":3855326637},{"date":"2024-03-08","current":-14.265501,"twenty":-28.429835,"median":-19.739727,"eighty":-12.677006,"marketCap":3412849975},{"date":"2024-03-15","current":-13.810051,"twenty":-28.429835,"median":-19.739727,"eighty":-12.869437,"marketCap":3303888912},{"date":"2024-03-22","current":-16.012055,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3830691962},{"date":"2024-03-28","current":-15.677398,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3750629268},{"date":"2024-04-05","current":-14.291244,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3419008643},{"date":"2024-04-12","current":-14.204114,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3398163918},{"date":"2024-04-19","current":-13.014002,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3113443925},{"date":"2024-04-26","current":-14.16253,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3388215300},{"date":"2024-05-03","current":-14.728134,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3523529410},{"date":"2024-05-10","current":-11.807571,"twenty":-28.429835,"median":-19.701371,"eighty":-12.750063,"marketCap":3499492533},{"date":"2024-05-17","current":-12.395706,"twenty":-28.429835,"median":-19.649302,"eighty":-12.578012,"marketCap":3673802218},{"date":"2024-05-24","current":-11.887699,"twenty":-28.429835,"median":-19.525695,"eighty":-12.436014,"marketCap":3523240446},{"date":"2024-05-31","current":-11.892506,"twenty":-28.429835,"median":-19.442778,"eighty":-12.367228,"marketCap":3524665321},{"date":"2024-06-07","current":-11.980646,"twenty":-28.429835,"median":-19.343656,"eighty":-12.253794,"marketCap":3550788026},{"date":"2024-06-14","current":-11.620073,"twenty":-28.433613,"median":-19.298009,"eighty":-12.177866,"marketCap":3443922415},{"date":"2024-06-21","current":-12.047953,"twenty":-28.43739,"median":-19.272637,"eighty":-12.168336,"marketCap":3570736273},{"date":"2024-06-28","current":-12.834804,"twenty":-28.441192,"median":-19.23983,"eighty":-12.143826,"marketCap":3803940784},{"date":"2024-07-05","current":-12.854035,"twenty":-28.441192,"median":-19.19834,"eighty":-12.143826,"marketCap":3809640283},{"date":"2024-07-12","current":-13.549541,"twenty":-28.441192,"median":-19.087715,"eighty":-12.143826,"marketCap":4015772172},{"date":"2024-07-15","current":-13.273902,"twenty":-28.441192,"median":-19.07844,"eighty":-12.143826,"marketCap":3934079350},{"date":"2024-08-02","current":-13.783512,"twenty":-28.490495,"median":-18.952635,"eighty":-12.102991,"marketCap":4085116080},{"date":"2024-08-09","current":-13.223111,"twenty":-28.490495,"median":-18.859161,"eighty":-12.102991,"marketCap":4080017425},{"date":"2024-08-16","current":-13.318007,"twenty":-28.490495,"median":-18.73003,"eighty":-12.102991,"marketCap":4109297550},{"date":"2024-08-23","current":-13.551356,"twenty":-28.490495,"median":-18.673323,"eighty":-12.102991,"marketCap":4181297857},{"date":"2024-08-30","current":-13.862488,"twenty":-28.490495,"median":-18.56764,"eighty":-12.102991,"marketCap":4277298267},{"date":"2024-09-06","current":-14.57498,"twenty":-28.490495,"median":-18.506355,"eighty":-12.102991,"marketCap":4497139206},{"date":"2024-09-13","current":-14.273182,"twenty":-28.490495,"median":-18.365921,"eighty":-12.102991,"marketCap":4404018808},{"date":"2024-09-20","current":-14.672987,"twenty":-28.490495,"median":-18.269068,"eighty":-12.102991,"marketCap":4527379335},{"date":"2024-09-27","current":-13.944938,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":4302738376},{"date":"2024-10-04","current":-14.184509,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":4376658691},{"date":"2024-10-11","current":-12.924425,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":3987857031},{"date":"2024-10-18","current":-14.522087,"twenty":-28.490495,"median":-18.096122,"eighty":-12.102991,"marketCap":4480819136},{"date":"2024-10-25","current":-13.818929,"twenty":-28.490495,"median":-18.063615,"eighty":-12.102991,"marketCap":4263858210},{"date":"2024-10-31","current":-13.916936,"twenty":-28.490495,"median":-18.025749,"eighty":-12.102991,"marketCap":4294098339},{"date":"2024-11-08","current":-14.109838,"twenty":-28.4958,"median":-17.957834,"eighty":-12.097778,"marketCap":4353618593},{"date":"2024-11-15","current":-15.175127,"twenty":-28.4958,"median":-17.957834,"eighty":-12.097778,"marketCap":4718781551},{"date":"2024-11-22","current":-15.302924,"twenty":-28.4958,"median":-17.88108,"eighty":-12.097778,"marketCap":4758520699},{"date":"2024-11-29","current":-15.307599,"twenty":-28.4958,"median":-17.77844,"eighty":-12.097778,"marketCap":4759974570},{"date":"2024-12-06","current":-15.32786,"twenty":-28.449873,"median":-17.629041,"eighty":-12.097778,"marketCap":4766274679},{"date":"2024-12-13","current":-14.707576,"twenty":-28.320039,"median":-17.452847,"eighty":-12.097778,"marketCap":4573394423},{"date":"2024-12-20","current":-13.98599,"twenty":-28.091929,"median":-17.328154,"eighty":-12.097778,"marketCap":4349013622},{"date":"2024-12-27","current":-13.710136,"twenty":-27.950529,"median":-17.237888,"eighty":-12.097778,"marketCap":4263235216},{"date":"2025-01-03","current":-13.608833,"twenty":-27.778537,"median":-17.194427,"eighty":-12.097778,"marketCap":4231734672},{"date":"2025-01-10","current":-12.868545,"twenty":-27.620773,"median":-17.134813,"eighty":-12.092564,"marketCap":4001538386},{"date":"2025-01-17","current":-14.601598,"twenty":-27.401353,"median":-17.062407,"eighty":-12.092564,"marketCap":4540440007},{"date":"2025-01-24","current":-16.19127,"twenty":-27.316594,"median":-17.006543,"eighty":-12.092564,"marketCap":5034756242},{"date":"2025-01-31","current":-16.964286,"twenty":-27.062663,"median":-16.935586,"eighty":-12.092564,"marketCap":5275129627},{"date":"2025-02-07","current":-17.065589,"twenty":-26.869288,"median":-16.889297,"eighty":-12.092564,"marketCap":5306630172},{"date":"2025-02-14","current":-20.522345,"twenty":-26.613063,"median":-16.886581,"eighty":-12.092564,"marketCap":6381525671},{"date":"2025-02-21","current":-21.919439,"twenty":-26.428477,"median":-16.886581,"eighty":-12.092564,"marketCap":6295613527},{"date":"2025-02-28","current":-21.462713,"twenty":-26.259509,"median":-16.886581,"eighty":-12.092564,"marketCap":6164434593},{"date":"2025-03-07","current":-21.12314,"twenty":-25.773705,"median":-16.884764,"eighty":-12.087351,"marketCap":6066903787},{"date":"2025-03-14","current":-20.654529,"twenty":-25.461185,"median":-16.884764,"eighty":-12.087351,"marketCap":5932311274},{"date":"2025-03-21","current":-21.438943,"twenty":-25.440831,"median":-16.884764,"eighty":-12.087351,"marketCap":6157607436},{"date":"2025-03-28","current":-20.674904,"twenty":-25.12508,"median":-16.884764,"eighty":-12.087351,"marketCap":5938163123},{"date":"2025-04-04","current":-18.318267,"twenty":-24.742094,"median":-16.884764,"eighty":-12.087351,"marketCap":5261299329},{"date":"2025-04-11","current":-16.24008,"twenty":-24.602553,"median":-16.762118,"eighty":-12.092564,"marketCap":4664410796},{"date":"2025-04-17","current":-17.737597,"twenty":-24.358761,"median":-16.744642,"eighty":-12.092564,"marketCap":5094521651},{"date":"2025-04-25","current":-17.897196,"twenty":-23.915799,"median":-16.742979,"eighty":-12.087351,"marketCap":5140361130},{"date":"2025-04-30","current":-18.662085,"twenty":-23.679617,"median":-16.742979,"eighty":-12.087351,"marketCap":5360049270}],"updateTime":1746105742395}}}